Please find attached the unaudited financial results for the quarter ended June 30, 2026
RESULTS
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 04 Aug 2026, 04:13 PM IST · BSE ID: 9befe3b3-47d7-42d0-a222-415d8a9bafd8
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its latest financial results, plans to raise up to Rs. 750 crore, and decided to sell four windmills.
🤖 AI Summary
- Thirumalai Chemicals Board approved unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27).
- Board approved raising funds up to Rs. 750 crores via debt and/or equity-linked instruments.
- Fundraise proceeds are for day-to-day operations and refinancing/repayment of existing debts.
- Sale of four windmills owned by the Company, with an installed capacity of 3.2 MW, was approved.
- Standalone revenue from operations for Q1 FY27 was Rs. 33,065 lakhs.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations Q1 FY27
Rs. 33,065 lakhs
Consolidated Revenue from operations Q1 FY27
Rs. 54,667 lakhs
Approved Fundraise Amount
Rs. 750 crores
Windmill Installed Capacity for Sale
3.2 MW
Reviewed Subsidiary Net Loss after Tax Q1 FY27
₹ 202 lakhs
🏢 How This Affects the Company
The approved sale of four windmills with 3.2 MW installed capacity indicates a divestment from non-core or less efficient assets, potentially optimizing the business portfolio. The fundraise, if successful, can support ongoing operations and reduce existing debt.
The approved fundraise of up to Rs. 750 crores aims to enhance liquidity, support day-to-day operations, and refinance/repay existing debts, potentially impacting the company's capital structure and interest expenses. The sale of windmills will likely result in a cash inflow.
Divesting the windmills means the company will no longer operate these specific power generation assets, simplifying operations in that segment. The fundraise provides capital for general corporate purposes, including daily operations.
Raising funds through debt or equity instruments will alter the company's financial leverage and share capital structure, introducing new financial risks or diluting existing equity. Utilizing funds for debt repayment could reduce financial risk.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to approve the fundraise, if required by regulations, as stated in the filing.
👤
Who Is Affected
Existing shareholders may face dilution if funds are raised via equity issuance. All shareholders are affected by changes in capital structure and debt levels.
🔍
Management Signal
The Board's decision indicates a focus on strengthening financial position through capital infusion and rationalizing non-core assets.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Details of the Rs. 750 crore fundraise instrument and terms.
Progress and completion of the windmill sale transaction.
Shareholder meeting for fundraise approval, if required.
MEDIUM RISK
The fundraise involves potential dilution or increased debt. Some subsidiary financial results were not reviewed by auditors.
💡 Investor Takeaway
Thirumalai Chemicals Board approved Q1 FY27 results, including standalone revenue from operations of Rs. 33,065 lakhs. A fundraise of up to Rs. 750 crores was approved for debt repayment and operations. The sale of four windmills (3.2 MW installed capacity) was also sanctioned.
⚖️ Strengths & Concerns
✅ Positives
- Approved fundraise of up to Rs. 750 crores through debt and/or equity instruments provides capital for operations and debt management.
- Divestment of 3.2 MW windmill capacity could streamline operations and free up capital from non-core assets.
⚠️ Concerns
- Consolidated total net loss after tax from one reviewed subsidiary was ₹ 202 lakhs for the quarter ended June 30, 2026.
- Two subsidiaries, whose interim financial results were not reviewed by auditors, reported a combined total net loss after tax of ₹ 12 lakhs.
📅 Company Track Record
A past filing on July 29, 2026, indicated that the Board meeting was scheduled for August 04, 2026, to consider the Q1 FY27 results and fund-raising. This current filing confirms the outcomes of that scheduled meeting.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What were Thirumalai Chemicals' standalone revenues for Q1 FY27?
Thirumalai Chemicals reported standalone revenue from operations of Rs. 33,065 lakhs for the quarter ended June 30, 2026.
What consolidated revenue did Thirumalai Chemicals report for Q1 FY27?
The consolidated revenue from operations for Thirumalai Chemicals was Rs. 54,667 lakhs for the quarter ended June 30, 2026.
What is the approved fundraise amount for Thirumalai Chemicals?
The Board has approved raising funds for an amount aggregating up to Rs. 750 crores.
What is the purpose of the approved fundraise by Thirumalai Chemicals?
The proceeds from the fundraise are intended for day-to-day operations and refinancing/repayment of existing debts of the Company.
What asset sale was approved by Thirumalai Chemicals' Board?
The Board approved the sale of four windmills with an installed capacity of 3.2 MW, located in Dindigul District, Tamil Nadu.
Questions based on this BSE filing only. For information purposes.